A carregar...

Differences in reimbursement listing of anticancer therapies in China: an observational study

OBJECTIVE: Access to highly priced anticancer medications usually requires insurance coverage. A first step towards coverage of such medications is their inclusion in reimbursement lists. We assessed listing for reimbursement in China between 2009 and 2018 of anticancer medications on the WHO’s Esse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Guan, Xiaodong, Zhang, Yichen, Wushouer, Haishaerjiang, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6955534/
https://ncbi.nlm.nih.gov/pubmed/31911513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!